Cardiac rhythm management (CRM) devices ensure the proper functioning of heart and regulate proper cardiac rhythm. These devices are utilized in patients with cardiac arrhythmias, which comprise cardiac disorders leading to irregular heartbeats. Arrhythmias are caused due to interferences in the electrical impulses in the heart. These conditions obstruct the blood flow, causes dizziness, chest pain, shortness of breath, and also stroke. The rising prevalence of arrhythmias is the primary factor driving this market. CRM devices help regulate the electrical impulses and regulate heartbeats which prolong the time and quality of life.

The current study on cardiac rhythm management devices encompasses a widespread information on the current market scenario and dynamics. Additionally, scrutiny of ongoing trends and in depth analysis of the market during the time scale, 2016 to 2026 has also been inculcated. The report provides future market scenarios and trends along the period from 2018 to 2026.

Market analysis and forecast estimations for the above mentioned segments have been provided in this study report for the period from 2016 to 2026 with values presented as US$ Mn. Additionally, respective growth rates for each segment have also been incorporated for the period from 2018 to 2026, keeping 2017 as the base year.

Qualitative factors such as market restraints, opportunities, and drivers that give a thorough understanding of the cardiac rhythm management devices market dynamics have been elaborated in this study. These qualitative factors would assist players in strategizing their products by understanding the current and future market trends. Competitive landscape of the current key market players and emerging industrial players has been included in this report. Company profiles for each key player with information pertaining to financial growth, market trends and product portfolio has also been presented in this study. The key players profiled are Abbott Laboratories, Inc., Biotronik, Inc., Boston Scientific Corporation, Integer Holdings Corporation, LivaNova, Plc., Medtronic Plc., Philips Healthcare Informatics, Inc. & ZOLL Medical Corporation.

Cardiac rhythm management (CRM) devices help regulate the heart rhythm during cardiac conditions such as arrhythmia. Of the available product types used in CRM, pacemakers hold a predominant position owing to an increased prevalence rate of arrhythmias. As per the report National Audit of Cardiac Rhythm Management Devices by heathrhythmalliance.org the annual new implant rate for pacemakers in England is 621/1 million population as of 2016 and that of defibrillators is 94/1 million population. Newer and advanced technologies of pacemakers have created additional demand for these devices, thus driving the market. For instance, the emergence of leadless pacemakers Micra by Medtronic Plc. is presumed to change the market trends and contribute to the remunerative growth in the forecast period from 2018 to 2026. The demand for defibrillators is also on the rise owing to increasing patient pool with cardiac diseases facilitated with constant adoption of unhealthy lifestyle and the emergence of wearable defibrillators which is presumed to gain demand during the period from 2018 to 2026.

The rising prevalence of arrhythmia across the globe has created a worldwide demand for cardiac rhythm management (CRM) devices, thus accounting for its global outreach. North America dominates the CRM devices market followed by Europe. As per selectusa.gov, United States holds the largest medical devices market position in the world accounting for a market size of $140 billion in 2015, which represents about 40% of the global market. Factors driving the North American market are the availability of suitable reimbursement plans, rise in geriatric population which are at a higher risk for cardiac diseases, and increasing disposable income. Europe also shows a lucrative growth for CRM devices market owing to the presence of manufacturers across the region, availability of favorable reimbursement options and the growing prevalence of arrhythmias in Europe. Asia Pacific market is expected to grow in the forecast period from 2018 to 2026 owing to factors such as rise in awareness on the availability of advanced CRM technologies, growing geriatric population, and rising medical tourism that facilitates the demand for CRM devices.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Cardiac Rhythm Management Devices market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Cardiac Rhythm Management Devices market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Cardiac Rhythm Management Devices market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2032.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Cardiac Rhythm Management Devices market?
• Which is the largest regional market for Cardiac Rhythm Management Devices market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Cardiac Rhythm Management Devices market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Cardiac Rhythm Management Devices market worldwide?